A previous study has shown that immunosuppressive neutrophils expressing CD10 and ALPL contribute to the resistance of anti-PD-1 therapy in hepatocellular carcinoma by facilitating the development of irreversible TEX [47]. The gene discussed is ALPL; the disease is hepatocellular carcinoma.